211 related articles for article (PubMed ID: 23956197)
1. Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal.
Lagunju IA; Brown BJ; Sodeinde OO
Pediatr Blood Cancer; 2013 Dec; 60(12):1940-5. PubMed ID: 23956197
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
[TBL] [Abstract][Full Text] [Related]
3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
4. Implementation of transcranial Doppler ultrasonography screening and primary stroke prevention in urban and rural sickle cell disease populations.
Hussain S; Nichols F; Bowman L; Xu H; Neunert C
Pediatr Blood Cancer; 2015 Feb; 62(2):219-223. PubMed ID: 25381872
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
Lagunju I; Brown BJ; Sodeinde O
Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
[TBL] [Abstract][Full Text] [Related]
6. PRIMARY STROKE PREVENTION IN CHILDREN WITH SICKLE CELL ANEMIA LIVING IN AFRICA: THE FALSE CHOICE BETWEEN PATIENT-ORIENTED RESEARCH AND HUMANITARIAN SERVICE.
Debaun MR; Galadanci NA; Kassim AA; Jordan LC; Phillips S; Aliyu MH
Trans Am Clin Climatol Assoc; 2016; 127():17-33. PubMed ID: 28066035
[TBL] [Abstract][Full Text] [Related]
7. Annual stroke incidence in Nigerian children with sickle cell disease and elevated TCD velocities treated with hydroxyurea.
Lagunju I; Brown BJ; Oyinlade AO; Asinobi A; Ibeh J; Esione A; Sodeinde OO
Pediatr Blood Cancer; 2019 Mar; 66(3):e27252. PubMed ID: 29797633
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
[TBL] [Abstract][Full Text] [Related]
9. Primary stroke prevention in Nigerian children with sickle cell disease (SPIN): challenges of conducting a feasibility trial.
Galadanci NA; Abdullahi SU; Tabari MA; Abubakar S; Belonwu R; Salihu A; Neville K; Kirkham F; Inusa B; Shyr Y; Phillips S; Kassim AA; Jordan LC; Aliyu MH; Covert BV; DeBaun MR
Pediatr Blood Cancer; 2015 Mar; 62(3):395-401. PubMed ID: 25399822
[TBL] [Abstract][Full Text] [Related]
10. Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease.
Mack AK; Thompson AA
J Pediatr Health Care; 2017; 31(2):145-154. PubMed ID: 27423528
[TBL] [Abstract][Full Text] [Related]
11. Big strokes in small persons.
Adams RJ
Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
[TBL] [Abstract][Full Text] [Related]
12. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
Adams RJ; Brambilla D;
N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
[TBL] [Abstract][Full Text] [Related]
13. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion.
Mazumdar M; Heeney MM; Sox CM; Lieu TA
Pediatrics; 2007 Oct; 120(4):e1107-16. PubMed ID: 17768181
[TBL] [Abstract][Full Text] [Related]
14. TCD in sickle cell disease: an important and useful test.
Adams RJ
Pediatr Radiol; 2005 Mar; 35(3):229-34. PubMed ID: 15703904
[TBL] [Abstract][Full Text] [Related]
15. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease.
Armstrong-Wells J; Grimes B; Sidney S; Kronish D; Shiboski SC; Adams RJ; Fullerton HJ
Neurology; 2009 Apr; 72(15):1316-21. PubMed ID: 19365052
[TBL] [Abstract][Full Text] [Related]
16. Stroke recurrence in Nigerian children with sickle cell disease treated with hydroxyurea.
Lagunju IA; Brown BJ; Sodeinde OO
Niger Postgrad Med J; 2013 Sep; 20(3):181-7. PubMed ID: 24287747
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler.
Bernaudin F; Verlhac S; Coïc L; Lesprit E; Brugières P; Reinert P
Pediatr Radiol; 2005 Mar; 35(3):242-8. PubMed ID: 15703901
[TBL] [Abstract][Full Text] [Related]
18. Health literacy and knowledge of chronic transfusion therapy in adolescents with sickle cell disease and caregivers.
Yee MEM; Meyer EK; Fasano RM; Lane PA; Josephson CD; Brega AG
Pediatr Blood Cancer; 2019 Jul; 66(7):e27733. PubMed ID: 30941859
[TBL] [Abstract][Full Text] [Related]
19. Capacity building and stroke risk assessment in Nigerian children with sickle cell anaemia.
Soyebi K; Adeyemo T; Ojewunmi O; James F; Adefalujo K; Akinyanju O
Pediatr Blood Cancer; 2014 Dec; 61(12):2263-6. PubMed ID: 25174615
[TBL] [Abstract][Full Text] [Related]
20. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
